Format

Send to

Choose Destination
See comment in PubMed Commons below
Arthritis Res Ther. 2009;11(3):117. doi: 10.1186/ar2715. Epub 2009 Jun 30.

Epidemiology, costs, and the economic burden of fibromyalgia.

Abstract

The assumption that fibromyalgia is associated with a major impact on the utilization of both healthcare and nonhealthcare resources has not been thoroughly supported by evidence-based data. Despite the differences between healthcare and sociopolitical systems in various countries, more recent results from epidemiological research now clearly demonstrate the socioeconomic burden of fibromyalgia and its comorbidities. The costs of the disease, calculated in single studies and countries, allow estimates for populations in other countries. The alarming results highlight the urgent need both for more research (including pathophysiology and epidemiology) and for the acceptance of emerging treatment challenges.

PMID:
19591654
PMCID:
PMC2714132
DOI:
10.1186/ar2715
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for BioMed Central Icon for PubMed Central
    Loading ...
    Support Center